A U.S. District Court recently ruled against Zydus and Lupin, finding Astellas's patent for Myrbetriq was not invalid. Both ...

The litigation was initiated by Astellas Pharma against Zydus Lifesciences concerning the validity of the ‘780 patent’, which ...

The ruling blocks Lupin and Zydus Life from selling their generic version of Mirabegron, the bioequivalent of Astellas' ...

Zydus MedTech has partnered with Brazil-based Braile Biomedica to commercialize innovative TAVI technology across Europe, ...

Zydus Lifesciences Ltd (NSE: ZYDUSLIFE) on Friday, April 11, announced that it has received final approval from the United ...

Lupin Ltd. and Zydus Lifesciences Ltd. shares fell sharply after a US court upheld Astellas Pharma's patent on Myrbetriq, ...

Stocks like NCL Industries, Persistent Systems, Repco Home Finance, JK Cement, Canara Bank, Union Bank of India, and Yatra ...

Easy Trip Planners Ltd, Dhani Services Ltd, Mahanagar Gas Ltd and Astrazeneca Pharma India Ltd are among the other losers in the BSE's 'A' group today, 16 April 2025.

Sun Pharma declined 0.93 per cent to Rs 1,689.35. About10 per cent of the Sun Pharma's US specialty revenues is formulated in ...

Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration to manufacture ...